Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
Open Access
- 1 January 2010
- journal article
- Published by Springer Science and Business Media LLC in Cardiovascular Diabetology
- Vol. 9 (1), 17
- https://doi.org/10.1186/1475-2840-9-17
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The Metabolic SyndromeEndocrine Reviews, 2008
- Is Serum Cystatin-C a Reliable Marker for Metabolic Syndrome?The American Journal of Medicine, 2008
- Metabolic Syndrome PandemicArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory IndividualsCirculation, 2007
- Metabolic Syndrome: A Multiplex Cardiovascular Risk FactorJournal of Clinical Endocrinology & Metabolism, 2007
- Associations of Serum Uric Acid With Markers of Inflammation, Metabolic Syndrome, and Subclinical Coronary AtherosclerosisAmerican Journal of Hypertension, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged MenJAMA, 2002
- Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetesCurrent Opinion in Lipidology, 1996
- Hypertension and Associated Metabolic Abnormalities — The Role of Insulin Resistance and the Sympathoadrenal SystemThe New England Journal of Medicine, 1996